Transgene : Availability of Preparatory Documents for the Combined General Meeting of May 26, 2021
information fournie par Boursorama CP 07/04/2021 à 17:45

Strasbourg, France, April 7, 2021, 5:45 p.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, announced that the documentation related to the Combined General Meeting (ordinary and extraordinary sessions) of Transgene's shareholders is available.